Study summary

The purpose of this study is to evaluate response rate, survival, safety and tolerability of YM155 given in combination with rituximab in subjects with Non-Hodgkin’s Lymphoma.

Additional Study Details

Phase
Phase 2
Product
  • YM155
  • Type
    Interventional
    Masking
    None (Open Label)
    Enrollment number
    43
    Show Additional Study Details

    Get more information

    Would you like more information about clinical trial sites that are recruiting participants for A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment? Contact us by filling out your information to the right and we’ll respond to you.

    • A patient
    • A caregiver
    • A parent
    • A healthcare provider
    • A patient advocate
    • Algeria
    • Argentina
    • Armenia
    • Australia
    • Austria
    • Belarus
    • Belgium
    • Bosnia And Herzegovina
    • Brazil
    • Bulgaria
    • Canada
    • Chile
    • China
    • Colombia
    • Croatia
    • Czech Republic
    • Denmark
    • Dominican Republic
    • Egypt
    • Estonia
    • Finland
    • Former Serbia and Montenegro
    • France
    • Georgia
    • Germany
    • Greece
    • Guatemala
    • Hong Kong
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Ireland
    • Israel
    • Italy
    • Japan
    • Jordan
    • Kazakhstan
    • Latvia
    • Lebanon
    • Lithuania
    • Macedonia
    • Malaysia
    • Mexico
    • Montenegro
    • Morocco
    • Netherlands
    • New Zealand
    • Norway
    • Panama
    • Peru
    • Philippines
    • Poland
    • Portugal
    • Puerto Rico
    • Republic of Korea
    • Republic of Moldova
    • Romania
    • Russian Federation
    • Saudi Arabia
    • Serbia
    • Singapore
    • Slovakia
    • Slovenia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Taiwan, Province of China
    • Thailand
    • Turkey
    • Ukraine
    • United Kingdom
    • United States
    • Vietnam

    By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

      Locations

      Contact Us
      Contact Us
      Withdrawn
      Site US810 University of Alabama at Birmingham
      Birmingham, AL, United States, 35294-3300
      Withdrawn
      Site US1895 Tower Cancer Research Foundation
      Beverly Hills, California, United States, 90211-1850
      Withdrawn
      Site US46 Washington Cancer Institute (MedStar Research Institute)
      Washington DC, DC, United States, 20010
      Withdrawn
      Site US2815 American Clinical Trials
      Pembroke Pines, FL, United States, 33028
      Completed
      Site US2778 John B. Amos Cancer Center
      Columbus, GA, United States, 31904
      Withdrawn
      Site US50 Rush University Medical Center
      Chicago, Illinois, United States, 60612
      Completed
      Site US55 Loyola University Hospital - Maywood
      Maywood, IL, United States, 60153
      Withdrawn
      Site US419 Louisiana State University School of Medicine
      Shreveport, Louisiana, United States, 71103
      Withdrawn
      Site US516 National Cancer Institute
      Bethesda, MD, United States, 20892-1457
      Withdrawn
      Site US667 Washington University School of Medicine
      St. Louis, MO, United States, 63110
      Completed
      Site US9 Mount Sinai School of Medicine
      New York, New York, United States, 10029
      Completed
      Site US2802 Mecklenburg Medical Group
      Charlotte, NC, United States, 28204
      Completed
      Site US2149 Gabrail Cancer Center Research
      Canton, Ohio, United States, 44718
      Withdrawn
      Site US1996 Providence Portland Medical Center
      Portland, OREGON, United States, 97213
      Withdrawn
      Site US960 Fox Chase Cancer Center
      Philadelphia, PA, United States, 19111
      Withdrawn
      Site US58 Medical Center for the University of South Carolina
      Charleston, SC, United States, 29425
      Completed
      Site US402 University of Texas Health Science Center - San Antonio
      San Antonio, TX, United States, 78229
      Withdrawn
      Site FR2701 CH de Blois
      Blois, France, 41150
      Completed
      Site FR1926 Institut Bergonie
      Bordeaux-cedex, France, 33076
      Withdrawn
      Site FR2625 Centre Hospitalier de Cannes
      Cannes, France, 6400
      Withdrawn
      Site FR2814 CHU Nantes Service hématologie Clinique
      Nantes, France, 44093
      Withdrawn
      Site FR1896 CHU Nice
      Nice, France, 6200
      Completed
      Site FR2700 Centre Antoine Lacassagne
      Nice, France, 06189
      Completed
      Site FR476 Hopital Saint Louis
      Paris, France, 75475
      Withdrawn
      Site FR1920 CHU de Poitiers
      Poitiers, France, 86021
      Completed
      Site FR1889 Centre de Lutte Contre le Cancer - Centre Henri Becquerel
      Rouen, France, 76038
      Completed
      Site FR1897 Hopital Bretonneau
      Tours, France, 37044
      Withdrawn
      Site FR2571 Hopitaux de Brabois
      Vandoeuvre, France, 54550
      Completed
      Site ES1349 Hospital del Mar
      Barcelona, Spain, 08003
      Completed
      Site ES1339 Hospital Universitario Ramon y Cajal
      Madrid, Spain, 28034
      Withdrawn
      Site ES1350 Hospital Universitario de la Princesa
      Madrid, Spain, 28006
      Completed
      Site ES1346 Hospital Universitario de Salamanca
      Salamanca, Spain, 37007
      Completed
      Site GB2702 Addenbrookes Hospital
      Cambridge, United Kingdom, CB2 0QQ
      Completed
      Site GB1928 St. Georges Hospital
      London, United Kingdom, SW17 0QT
      Completed
      Site GB2624 The Christie NHS Foundation Trust
      Manchester, United Kingdom, M20 4BX
      Withdrawn
      Site GB2012 Nottingham City Hospital
      Nottingham, United Kingdom, NG5 1PB
      Completed
      Site GB1903 Oxford Radcliffe Hospital
      Oxford, United Kingdom, OX3 7LJ
      Withdrawn
      Site ES1344 Hospital Universitario Vall D'Hebron
      Barcelona, Spain, 08035
      Completed
      Site ES2967 Hosptial Universitario Madrid Sanchinarro
      Madrid, Spain, 28050
      Withdrawn
      Site US2879 Yale University School of Medicine
      New Haven, CT, United States, 06520

      Frequently Asked Questions

      Are clinical trials only for people with advanced cancer?

      While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

      Will I have to stop my current treatment to participate in a clinical trial?

      Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

      Should I be worried about getting a placebo?

      In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

      Do I need a referral from my doctor to take part in a study?

      Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

      Explore More

      1

      What are clinical trials?

      2

      Why are Clinical Trials Important?

      3

      Why Participate in a Clinical Trial?